Immunome, Inc.IMNMNASDAQ
Loading
Year-over-year book value per share growth
| Period | Value |
|---|---|
| Q4 2025 | 142.03% |
| Q3 2025 | -3.04% |
| Q2 2025 | -19.98% |
| Q1 2025 | 33.86% |
| Q4 2024 | -19.06% |
| Q3 2024 | -15.72% |
| Q2 2024 | -84.71% |
| Q1 2024 | 407.21% |
| Q4 2023 | 996.83% |
| Q3 2023 | -34.96% |
| Q2 2023 | -32.72% |
| Q1 2023 | -17.13% |
| Q4 2022 | -27.86% |
| Q3 2022 | -24.19% |
| Q2 2022 | -19.64% |
| Q1 2022 | -22.62% |
| Q4 2021 | -12.48% |
| Q3 2021 | -13.29% |
| Q2 2021 | 49.44% |
| Q1 2021 | -12.25% |
| Q4 2020 | 182.93% |
| Q3 2020 | -599.95% |
| Q2 2020 | 0.00% |
| Q1 2020 | 100.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |